Eighteen months ago, Alibaba Group Holding Ltd. was under U.S. scrutiny because counterfeiters were selling goods on its website. Now it’s heading for what may be the nation’s biggest initial public offering since 2008.
Activists gathered with signs outside Merck’s East London offices last week, protesting the drugmaker’s involvement in a campaign to delay South Africa’s proposal to allow low-cost copies of patented drugs.
Patent filings around the world increased at a greater rate in 2012 than at any time in the previous 18 years, according to a report from the World Intellectual Property Organization, a United Nations agency.
AstraZeneca Plc , the U.K.’s second- largest drugmaker, said it filed a lawsuit yesterday claiming Watson Pharmaceuticals Inc. is infringing a patent on the active ingredient in cholesterol medicine Crestor.
Google Inc., creator of the world’s most-used search engine, asked a federal court in San Francisco to declare it doesn’t infringe two patents belonging to the University of California and its licensee Eolas Technologies Inc. of Tyler, Texas.